Citalopram for pediatric functional abdominal pain: a randomized, placebo‐controlled trial
Conclusions & InferencesOverall, we found a trend toward the effectiveness of citalopram in the treatment of children with FAP. Trials with longer treatment duration in larger samples of patients are required in this regard.
In a randomized, placebo‐controlled trial, children with functional abdominal pain received either citalopram 20 mg/day or placebo for 4 weeks and were followed up for 8 weeks after medication period. Citalopram, when taken as prescribed, achieves a higher treatment response rate over placebo based on self‐rated pain severity scale and also achieves more reduction in physician‐rated global severity score.
Source: Neurogastroenterology and Motility - Category: Gastroenterology Authors: H. Roohafza, Z. Pourmoghaddas, H. Saneian, A. Gholamrezaei Tags: Original Article Source Type: research
More News: Anxiety | Celexa | Children | Citalopram | Depression | Gastroenterology | Neurology | Pain | Pediatrics | Study